During regulated exocytosis in synaptic transmission and neuroendocrine secretion, a pool of neurotransmitter or hormone-containing vesicles accumulate at the plasma membrane awaiting the signal for rapid and synchronous release. To create this readily releasable pool, the molecular machinery of regulated exocytosis needs to bring the vesicles into an activated state that is as close to fusion as possible, all the while preventing them from fusing prematurely 1-3 . Calciumdependent exocytosis is controlled by the pairing between cognate v-and t-soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins, which assemble like a zipper across the membranes that are destined to fuse, thus facilitating their close apposition and subsequent merging 4, 5 . The assembly of such membrane-bridging complexes, called SNAREpins, is further manipulated by SNARE-interacting proteins to allow fusion to be clamped or triggered where and when necessary 1 . Complexin (CPX) and synaptotagmin (SYT) proteins are important regulators of calcium-dependent neurotransmitter release showing an intriguing dual activatory-inhibitory role in membrane fusion 2, [6] [7] [8] [9] .
During regulated exocytosis in synaptic transmission and neuroendocrine secretion, a pool of neurotransmitter or hormone-containing vesicles accumulate at the plasma membrane awaiting the signal for rapid and synchronous release. To create this readily releasable pool, the molecular machinery of regulated exocytosis needs to bring the vesicles into an activated state that is as close to fusion as possible, all the while preventing them from fusing prematurely [1] [2] [3] . Calciumdependent exocytosis is controlled by the pairing between cognate v-and t-soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins, which assemble like a zipper across the membranes that are destined to fuse, thus facilitating their close apposition and subsequent merging 4, 5 . The assembly of such membrane-bridging complexes, called SNAREpins, is further manipulated by SNARE-interacting proteins to allow fusion to be clamped or triggered where and when necessary 1 . Complexin (CPX) and synaptotagmin (SYT) proteins are important regulators of calcium-dependent neurotransmitter release showing an intriguing dual activatory-inhibitory role in membrane fusion 2, [6] [7] [8] [9] .
In vitro, CPX inhibits SNARE-mediated liposome-liposome 10 or cell-cell fusion 11 , and this inhibition is relieved by the addition of calcium and SYT. In contrast to this clamping effect, CPX can also activate SNAREpin assembly and membrane fusion, when added to liposomes that have already been bridged by SNAREpins 12, 13 . In vivo studies have also led to seemingly contradictory data. Notably, knockout of CPX in mouse synapses decreases both spontaneous and calcium-evoked exocytosis 14 , indicating a positive requirement, whereas deletion of CPX in Drosophila melanogaster or in Caenorhabditis elegans synapses increases spontaneous release (negative role) but also decreases calcium-evoked release (positive role) 3, 15 , thus implying a clamping function. Clamp and activator functions seem to selectively reside in the different structural domains that comprise the CPX molecule [16] [17] [18] , which consist of an N-terminal domain (activator), an accessory helical domain (inhibitor), a central helical domain (necessary as the main binding site to the SNARE complex) and a C-terminal domain (of unclear function 13, 16 ).
Altogether, these disparate observations have led to a controversy concerning CPX and its role in exocytosis. The simplest explanation would be that CPX is both a clamp and an activator, acting at different stages of SNARE assembly 1 . Despite these recent important insights into the structure-function properties of CPXs, the physical-chemical mechanism by which one relatively small protein can carry out such opposite functions, all within a few milliseconds, remains unclear.
To investigate the molecular mechanism underlying the function of CPX, we took advantage of recent advances in surface force apparatus (SFA) measurements, which have previously allowed us to measure simultaneously the distance and the interaction energy between SNARE proteins embedded into lipid bilayers and thus to identify intermediate states along their assembly pathway 19 . In our SFA system, two opposing bilayers are brought into closely controlled apposition, one containing the synaptic v-SNARE VAMP2 and the other containing the synaptic t-SNARE, a complex of Stx1a and SNAP25 (derived from rat and mouse). These SNAREs are anchored to the bilayers by covalent attachment at their C termini to the lipid phosphatidylethanolamine rather than by their natural transmembrane domain. To our knowledge, this is the only experimental system that can provide direct energetic measurements of SNARE complexes assembling between bilayers, closely mimicking the geometry that occurs in cells.
Here we introduce the soluble form of human complexin-3 and its various functional domains into this SNARE bilayer-SFA experiment a r t i c l e s to address the following fundamental questions. (i) How does CPX affect the structural-energetic landscape of SNAREpins as they assemble across membranes? (ii) What is the role of the different functional domains of CPX in SNAREpin activation and/or clamping? To answer these questions, we approached SNARE bilayers down to molecular contact distances and then separated them from each other, all the while measuring at regular intervals (30 s) both distances (± 0.1 nm) and forces (± 1 µN) of interaction. After carrying out several approachseparation cycles in the absence of CPX, we separated SNARE bilayers several thousands of nanometers apart and then incubated them with CPX for 2 h before initiating additional approach-separation cycles. We repeated the process on the same SNARE bilayers, using increasing concentrations of CPX, ranging from 0.1 µM to 3 µM.
In the presence of CPX, the interaction energy versus distance profile of SNARE bilayers showed substantial changes consistent with an initial activation of cognate SNARE binding evident during the approach phase, followed by a block to completion of SNAREpin assembly evident during the separation phase of the experiment.
RESULTS

CPX activates N-terminal assembly of SNAREpins
Before CPX is added ( Fig. 1a and our previous work 19 ), SNARE bilayers initially repel each other during the approach phase in a nonspecific polymer-like manner between d = 20 nm and d = 10 nm (d is the separation between the opposing bilayer surfaces, which is by definition 0 when the bilayers are in contact) and with an exponential decay length of 8 ± 2 nm. At a distance d binding = 9 ± 1 nm, the SNAREs start assembling, leading to a slower increase of the repulsion, resembling a plateau. Then, when the bilayers are brought even closer (down to 4 ± 1 nm), SNARE assembly is completed to the maximum extent possible (recall that the two bilayers cannot fuse because of the lipid anchors), and a stiff repulsion is encountered that persists down to d contact = 2.5 ± 1.5 nm. This corresponds to the compression of partially assembled (~70%) SNAREpins 19 .
After incubation with CPX ( Fig. 1) , these features are conserved qualitatively; however, all events occur at substantially larger distances ( Table 1) . Notably, the distance d binding at which SNAREpins start assembling increases up to 15 ± 1 nm in the presence of CPX (compare distances at e of ~10 k B T in Fig. 1a-c , and see also Figs. 2 and 3) . In addition, the polymer-like repulsion has a larger decay length after incubation with CPX ( Table 1 ), indicating that either SNARE or both SNAREs extend their sequence further away from the bilayer surface. This would explain the increase in reactivity of v-SNAREs with t-SNAREs at greater separations (in other words, the activation of SNAREpin assembly) when CPX is present.
To further test this conclusion, we conducted experiments during which SNARE bilayers were approached down to a specific minimal distance (d min , which was systematically varied from one experiment to the next) at which they were allowed to react for at least 30 min (which is sufficient for maximum adhesion to occur 19 ) . The bilayers were then separated, and the energy required to do this was determined. If there is no assembly at d min , then there is no binding energy to overcome during separation; but if assembly occurs at d min , then force is needed to separate the bilayers away from d min , which measures the average adhesion (binding) energy per SNAREpin (Figs. 2 and 3) .
In the absence of CPX, there is no adhesion until d min is less than 9 ± 1 nm, confirming that isolated SNAREpins can only start assembling when bilayers are 9 ± 1 nm apart or closer. CPX increases d min to 15 ± 1 nm, which means that SNAREs can now assemble when the bilayers are 50% further away, providing an explanation of why CPX activates SNARE assembly.
CPX clamps C-terminal assembly of SNAREpins
In the absence of CPX and upon separation, SNARE bilayers remain bound through membrane-bridging SNAREpins until d unbinding = 9 ± 2 nm, at which point the bilayers jump out as the SNAREpins are pried apart, and show a binding energy of ~35 k B T (ref. 19) . When a saturating concentration of CPX is added, full separation of the two SNARE a r t i c l e s bilayers now occurs at d unbinding = 16 ± 2 nm (Fig. 1c) . The distance at which the jump-out occurs is related to the degree of assembly of CPXbound SNAREpins. To estimate this, we treated the unassembled part of SNARE proteins as random polymers and determined the extent to which these unstructured sequences are stretched before the adhesive jump. A jump-out at 16 nm suggests that the number of C-terminal amino acids that are not yet zippered into the SNAREpin structure is 24-44 on each of the v-and t-SNARE sides (see Supplementary Discussion). On the v-SNARE side, this would correspond to a region bounded by the hydrophobic layers −2 and +4 (ref. 20) . On average, the SNAREpin is thus about 50% zippered (down to layer +1) when bound to CPX. This would be consistent with the pattern of sensitivity and resistance to tetanus and botulinum toxins that indicates a similar degree of zippering for SNAREs that are functionally clamped in vitro 11 , and for the readily releasable pool of synaptic vesicles at the neuromuscular junction in vivo 21 . CPX thus acts as an inhibitor (a clamp) of SNAREpin assembly by blocking C-terminal zippering of membrane proximal domains of cognate v-and t-SNARE proteins.
The detailed behavior of adhesion as a function of less-than-saturating concentrations of CPX allows us to estimate the affinity of CPX for assembling SNAREpins at the interface between the apposed membranes. Specifically, at intermediate CPX concentrations (Fig. 1b,d) , a two-stage unbinding process is now observed: the bilayers first jump apart at 10 nm but remain adherent (first jump-out), then completely separate at 16 nm (second jump-out). The average energy per SNAREpin associated with the first jump-out, e 1 , vanishes as the CPX concentration increases, whereas that associated with the second jump-out, e 2 , increases up to about 15 k B T. The concentration dependence indicates that the first jump-out corresponds to a subpopulation of free SNAREpins, whereas the second jump-out corresponds to a subpopulation of CPX-bound SNAREpins (of lower energy), and this allows us to estimate the affinity constant (~0.2 µM) for the binding of CPX to the SNAREpin (Supplementary Discussion and Fig. 4) .
Notably, the energy necessary to disassemble SNAREpins, which is also the energy released upon SNAREpin assembly and made available to drive close membrane apposition, is thus much smaller in the presence of CPX, which explains how CPX can clamp fusion.
CPX creates an activated and clamped intermediate state
Overall, CPX therefore appears to have a dual role in fusion, being both an activator and an inhibitor of SNAREpin assembly. It is an activator of SNAREpin early during its N-terminal assembly, but it prevents C-terminal completion of SNAREpin zippering and therefore clamps fusion by retaining SNAREpins in a lower energy state. The thermodynamic mechanism at the origin of the dual activatoryinhibitory function of CPX is illustrated with the energy landscape representation in Figure 5 . In the absence of CPX, once cognate v-and t-SNAREs have overcome a nonspecific polymer-like repulsion due to their confinement between lipid bilayers, they start binding (d = 9 ± 1 nm), and their assembly then spontaneously progresses down to an interbilayer distance d = 4 ± 1 nm to form a highly energetic (~35 k B T) SNAREpin. In this case, the energy landscape of SNAREpin folding thus consists of a single repulsion barrier (for N-terminal assembly) followed by a deep adhesion well. In the presence of CPX, cognate SNAREs begin to assemble at a larger distance (d = 15 ± 1 nm) to form a SNAREpin of lower energy (~15 k B T) whose membrane-proximal zippering is inhibited. On the energy landscape of SNAREpin folding, this translates into the appearance of an intermediate binding state flanked with a first repulsion barrier at a larger distance (N-terminal assembly is facilitated) and a second repulsion barrier at a short distance (C-terminal assembly is prevented).
The seemingly contradictory activatory-inhibitory effects of CPX on membrane fusion thus come from the common mechanism of the creation of an intermediate energetic state in the folding pathway of SNAREpins, which makes the SNAREs find each other at a larger distance but traps the SNAREpin in this state until an external action makes it overcome the repulsion barrier toward further zippering.
In these studies, we use lipid-anchored SNAREs from which the transmembrane anchors have been removed, for two reasons. First, neither we nor other SFA users have succeeded in reproducibly forming bilayers containing functional transmembrane proteins. Second, and more fundamentally, including the transmembrane anchors would preclude establishing reproducible measurements of prefusion SNARE assembly because the approaching bilayers would probably fuse on their first close approach. As a result we could never do the pull-away portion that actually reveals the binding energy. Using lipid anchors instead of transmembrane anchors prevents fusion 22 and therefore allows us to measure adhesion and to take the bilayers through repetitive cycles of approach-separation to establish the reproducibility of measurements. It is certainly true that the absence of transmembrane domains might have some quantitative effect on a r t i c l e s the energetic landscape, but this is expected to be small because the transmembrane domains zipper last, after the cytoplasmic domains.
The t-SNARE is the primary target for CPX action
The targets of regulatory factors can include individual SNARE proteins (to regulate their accessibility or their intracellular targeting), partially assembled fusion machine SNAREpins (to regulate their rate or extent of assembly) or fully assembled postfusion cis-SNARE complexes (to regulate their disassembly). The efficiency of synaptic vesicle exocytosis can be modulated by manipulating the pools of SNAREs in any of these three states. What, then, is the primary target for CPX action? SFA experiments conducted on symmetrical t-SNARE versus t-SNARE or v-SNARE versus v-SNARE systems (Fig. 6) show that CPX targets the t-SNARE but not the v-SNARE. CPX increases both the polymer decay length and the distance at contact between t-SNARE bilayers, but it does not change the interaction profile between v-SNARE bilayers. Isothermal titration calorimetry (ITC) experiments conducted on soluble SNARE domains further show that CPX binds to t-SNARE (but not to v-SNARE) with an affinity of about 2 µM ( Supplementary  Fig. 1 ). This is also in good agreement with single-molecule fluorescence and co-flotation experiments conducted on membraneembedded SNARE proteins, which showed that complexin-1 binds to and stabilizes the (1:1) Stx1a-SNAP25 acceptor complex 23, 24 . CPX would thus prepare and facilitate the association of cognate SNAREs through its interaction with the t-SNARE.
CPX domains responsible for SNAREpin activation and clamping
Complexin proteins consist of four structurally distinct domains, which are, in the case of the human complexin-3 studied here, an N-terminal domain (residues 1-25), an accessory helix (residues 26-57), a central helix (residues 58-80) and a C-terminal domain (residues 81-158). Structural studies show that CPX binds in an antiparallel manner to the fully assembled postfusion state of the SNARE complex through its central helix [25] [26] [27] . In the X-ray structure, the central helix binds in the groove between VAMP and syntaxin helices, whereas the accessory helix does not contact the SNARE complex. Structure-function analyses in a cell-cell fusion assay in vitro 28 and by electrophysiology in vivo 16, 18 suggest that each domain of CPX contributes uniquely. The N-terminal domain was shown to have an activating effect, whereas the accessory helix was inhibitory. Furthermore, it has been proposed that the central helix, in addition to stabilizing the SNARE complex 27 , could strategically position the N-terminal domain and the accessory helix for their interaction with SNAREs and/or lipid membranes. The role of the C-terminal domain is not clear, as both activatory and inhibitory functions have been reported 13, 16 .
To elucidate how functional domains of CPX work on SNAREpin assembly to activate or inhibit fusion, we introduced various CPX mutants into the SFA experiment. A CPX mutant containing only the accessory and the central helices, CPX , previously identified in the cell-cell fusion assay as the minimum clamping domain 28 ( Supplementary Fig. 2) , behaved exactly like wild-type CPX when added to SNARE bilayers ( Fig. 3 and Table 1 ). This shows that the most extreme N-and C-terminal sequences of CPX are not required for the activating and clamping effects, as observed in our SFA system. When the accessory helix was deleted (CPX 58-158 ) or mutated (CPX(K26A)) to lose clamping function 28 (Supplementary Fig. 2 ), activation (assembly at d > 9 nm) was retained, but the intermediate state became Figure 3 CPX activates and clamps SNAREpin assembly. Experiments similar to those presented in Figure 2 were repeated with many different d min in the presence of various CPX variants (each data point corresponds to a single approach-separation cycle). Such experiments allow one to determine exactly at which distance SNAREpins start assembling and to measure the energy of assembly at a given distance. All data points were obtained with 1 µM of CPX, because at this concentration, >80% of the SNAREpins are bound to CPX (affinity better than 0.2 µM; see Fig. 4 ). In the absence of CPX, SNAREs do not begin to assemble until the bilayers are within ~9 nm, and they zipper into highly energetic (~35 k B T Figure 4 Affinity of CPX variants for the SNAREpin. The dissociation constants K between the SNAREpin and the wild-type CPX (purple), the nonclamping CPX(K26A) mutant (green) or the superclamping CPX(Q37A R41F Y44A Q48L) mutant (red) were estimated from the fraction of clamped SNAREpins (which is directly related to e 2 , the adhesion due to CPX-bound SNAREpins in Fig. 1d ) at various CPX concentrations. For each mutant, at least three different concentrations were tested and the plot 1/e 2 versus 1/[CPX] was fitted by a straight line whose slope gives the dissociation constant K (Supplementary Discussion and Supplementary Table 1 ). In the case of the superclamping mutant, only the two highest concentrations are showed here for clarity (the fit was, however, deduced from three different protein concentrations). The nonclamping CPX mutant shows a slightly lower affinity for SNAREpins than wild-type CPX, whereas the superclamping CPX mutant shows a much higher affinity for SNAREpins. a r t i c l e s unstable and the more zippered state then prevailed at d min < 9 nm ( Fig. 3 and Supplementary Fig. 3 ). These mutants were thus able to create the intermediate state, but the energetic barrier toward further zippering (barrier at short distance) was now too low (less than 25 k B T; Supplementary Discussion and Supplementary Fig. 4 ) and could easily be overcome on the time scale of SFA measurements (~1 min).
Results obtained with the CPX 58-158 mutant show that the central helix is sufficient for the activation function of CPX and for inducing the intermediate state. They also show that the accessory helix is required to have a repulsion barrier at short distance that is high enough to trap the SNAREpin in this intermediate state and thus stabilize clamping (even when the v-and t-SNAREs are forced to be in very close contact with the SFA; see Supplementary Discussion). As suggested previously 18, 29 , the accessory helix probably does so by binding to C-terminal residues of the t-SNARE, thereby occupying the v-SNARE binding site ( Supplementary Figs. 4 and 5) .
In the CPX(K26A) mutant experiment, the altered accessory helix could thus be displaced from the t-SNARE at short interbilayer distance. This suggests that binding of the native accessory helix of CPX to the t-SNARE is not very strong and mainly controlled by the Lys26 residue. SFA titration data indeed showed that the overall affinity of the SNAREpin for the wild-type CPX or the CPX(K26A) mutant are similar: (Supplementary Discussion and  Fig. 4) , and ITC experiments showed that binding of the accessory helix of CPX to the C terminus of t-SNARE is substantially weakened by the mutation K26A (Supplementary Fig. 5 ). In addition, because both the CPX 58-158 and the CPX(K26A) mutants showed the same distance at contact (d contact ~ 5-6 nm) as wild-type CPX (Table 1) , the central helix of CPX probably stays bound to the SNAREpin at short interbilayer distance, after displacement of the accessory helix 30 (the distance at contact is directly related to the thickness of protein complexes between two compressed bilayers).
The final CPX mutant tested, CPX(Q37A R41F Y44A Q48L), was designed to improve the sequence similarity between the accessory helix of CPX and the C terminus of VAMP2 (ref. 29 ) and thus to increase the affinity of the accessory helix for membrane-proximal residues of the t-SNARE. In the cell-cell fusion assay, this mutant showed a much higher capacity to inhibit fusion and, as such, was identified as a 'superclamping' CPX mutant 29 (Supplementary Fig. 2) . When added to the SFA experiment, this superclamping mutant creates the same intermediate energetic state as does wild-type CPX ( Fig. 3 and Supplementary Fig. 3 ) but does so at about one-tenth the concentration (K superclamp ~ 10 nM; Supplementary Discussion and Fig. 4) . This explains energetically how increasing the affinity of the accessory helix for the C terminus of t-SNARE improves the clamping efficiency of CPX.
It is important to note that the CPX-specific nature of the observed features is clear, and alternate explanations such as nonspecific aggregation of CPX are not tenable because approach and separation curves can be quantitatively repeated many times without hysteresis (hysteresis is a hallmark of nonspecific binding in the SFA) because CPX mutations affect the SFA curves in a manner fitting with functional analysis and because the specific features we study only occur when CPX is added. Figure 5 CPX reshapes the energy landscape of SNAREpin folding. CPX digs an adhesion well in the pathway of cognate SNARE assembly. In the absence of CPX (black), v-and t-SNAREs need to overcome a nonspecific repulsion barrier (ending at an interbilayer distance d ~ 9 nm) to begin their assembly and form highly energetic (~35 k B T) SNAREpins. In the presence of CPX (purple), an intermediate energetic state of lower energy (~15 k B T) appears on the folding pathway of SNAREpin. The nonspecific repulsion barrier still exists but is displaced further away, thus allowing v-and t-SNAREs to bind at a larger distance (~15 nm). This barrier at large distance is generated by the central helix of CPX, which facilitates N-terminal assembly of SNAREpins most likely by increasing the exposure of t-SNAREs (see text and Fig. 6 for details). It is followed by a second repulsion barrier at short distance generated by the accessory helix of CPX, which prevents further SNAREpin assembly by competing with the v-SNARE for C-terminal binding to the t-SNARE. The dashed lines indicate the regions that are not observed in the SFA. Because the intermediate state is stable over an hour (typical duration of the contact time between two SNARE bilayers in the SFA), the energy difference between the binding energy and the barrier height (that is, the activation energy) must be higher than 30 k B T (see Supplementary Discussion). . No adhesion is observed in both cases, either with or without CPX (during the separation phase, the interaction force continuously decreases until reaching the zero baseline). CPX affects the interaction profile of t-SNARE but not v-SNARE bilayers. In the presence of CPX, the long-range repulsive forces between t-SNARE bilayers begin 10 nm further away (the t-SNAREs see each other at a larger distance), and the distance at contact is about 1 nm larger (the protein layer between the two compressed bilayers is now thicker), suggesting that CPX binds to t-SNARE and increases its exposure toward solution (makes it more erected on the bilayer surface). Note that the repulsion profile between two v-SNARE bilayers is stronger than that between two t-SNARE bilayers, which is consistent with the fact that v-SNARE is largely unstructured. The insets show the approaching phase of the interaction profiles on a semi-log scale to more clearly display the repulsive forces. 18, 29 . A recent X-ray study 31 suggests that, in this process, the central and accessory helices come from two neighboring CPX molecules in a zigzag array that forms at the interface of the apposed bilayers. Disruption of the bonds between accessory helices and the SNAREpins to which they bind in the array leads to a conformation switch in CPX and triggers membrane fusion 32 .
To regulate exocytosis, clamp-activator proteins grapple with SNAREs to sequentially facilitate and then inhibit their assembly across two fusing membranes 1 . Our SFA data show that CPX accomplishes its dual activatory-inhibitory task by means of a single elegant mechanism, reshaping the energy landscape of cognate SNARE assembly to create a single intermediate energetic state. SNAREpin zippering is first facilitated at large separations and then prevented at small separations when SNAREpins are about half assembled and the bilayers are within molecular contact range. We speculate that in vivo Ca 2+ -bound SYT mechanically provides the energy required to lower the repulsion barrier toward further zippering by physically displacing the accessory helix of CPX, thus triggering membraneproximal assembly of SNAREpins and synaptic vesicle fusion.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. 
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